BridgeBio Oncology Therapeutics, Inc. (BBOT) Free cash flow 2024–2025
BridgeBio Oncology Therapeutics, Inc. (BBOT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$114.5MFY2025 · since FY2024: -$55.1M → -$114.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$114.5M | -107.9% |
| FY2024 | -$55.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice